StockWatch
·
Refineries & Marketing
Business Update24 Jun 2026, 04:11 pm

Karkinos Healthcare Completes 1 Lakh HPV DNA Tests

AI Summary

Reliance Industries' subsidiary, Karkinos Healthcare, has achieved a significant milestone by completing HPV DNA screening for over one lakh women across India. This accomplishment strengthens India's cervical cancer prevention efforts by expanding access to high-quality screening and follow-up care. Karkinos Healthcare's model utilizes a digitally enabled care continuum, integrating community outreach, HPV DNA testing, navigation, and treatment linkage to address challenges in screening access and patient follow-up. The initiative aims to reach underserved communities and contribute to India's goal of eliminating cervical cancer.

Key Highlights

  • Karkinos Healthcare, a Reliance subsidiary, screened over 100,000 women.
  • Milestone strengthens India's cervical cancer prevention efforts.
  • Focus on digitally enabled care continuum and follow-up.
  • Aims to expand access to screening in districts and small towns.
  • Supports India's goal of cervical cancer elimination.